Abstract CT136: Phase Ib study of Decitabine in combination with Gemcitabine in treatment of refractory pancreatic adenocarcinoma and advanced soft tissue or bone sarcomas
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-ct136
Abstract: Background and Objectives: Metastatic pancreatic adenocarcinoma is the second leading cause of cancer related death in the US with limited therapeutic options. Preclinical data have shown that methylation alongside other epigenetic modifications play a role… read more here.
Keywords: phase; combination gemcitabine; pancreatic adenocarcinoma; decitabine combination ... See more keywords
Chidamide and Decitabine in Combination with a HAG Priming Regimen for Acute Myeloid Leukemia with TP53 Mutation.
Sign Up to like & getrecommendations! Published in 2022 at "Acta medica Okayama"
DOI: 10.18926/amo/63213
Abstract: We analyzed the treatment effects of chidamide and decitabine in combination with a HAG (homoharringtonine, cytarabine, G-CSF) priming regimen (CDHAG) in acute myeloid leukemia (AML) patients with TP53 mutation. Seven TP53 mutated AML patients were… read more here.
Keywords: chidamide decitabine; combination hag; acute myeloid; tp53 ... See more keywords